This is the authors' abstract. We don't add key points for this paper.
Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly semaglutide and tirzepatide, have introduced new perioperative considerations in oral and maxillofacial surgery because of their effects on gastric emptying and aspiration risk. Methods A structured narrative review was conducted using PubMed/MEDLINE, Scopus, ScienceDirect, and SciELO to identify studies published between 2019 and 2026 addressing perioperative management of GLP-1RA users undergoing surgery. Results Evidence indicates that GLP-1RAs may increase residual gastric contents despite standard fasting, particularly during procedures requiring sedation or general anaesthesia. Most recommendations are based on observational studies, guidelines, and expert consensus, with limited evidence specific to oral and maxillofacial surgery. Conclusions Individualised perioperative assessment considering gastrointestinal symptoms, anaesthetic modality, and surgical complexity appears preferable to universal discontinuation strategies. Prospective oral and maxillofacial surgery–specific studies are needed to establish perioperative protocols.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sérgio Honório (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: